Home » Innovation and health » : National Survey of Drug-Resistant Tuberculosis in China Drug-resistant tuberculosis.

Yanlin Zhao, Ph.D www.bluepill.net ., Shaofa Xu, M.D., Lixia Wang, M.S., Daniel P. Chin, M.D., Shengfen Wang, Ph.D., Guanglu Jiang, B.S., Hui Xia, M.S., Yang Zhou, M.S., Qiang Li, M.S., Xichao Ou, M.S., Yu Pang, Ph.D., Yuanyuan Song, B.S., Bing Zhao, B.S., Hongtao Zhang, Ph.D., Guangxue He, B.S., Jing Guo, Ph.D., and Yu Wang, M.D.: National Survey of Drug-Resistant Tuberculosis in China Drug-resistant tuberculosis, especially multidrug-resistant and extensively drug-resistant tuberculosis, is certainly a significant threat to the control of tuberculosis world-wide.1-3 To time, estimates of drug-resistant tuberculosis in countries with the best burden of tuberculosis, including China, have relied on regional or regional surveys.

Specifically, researchers looked at overall conditions and health such as asthma and bodyweight. They also viewed medications children were taking, any disabilities or medical problems, and social and economic circumstances. The experts then adjusted their findings to take into account the mother’s social environment and weight, and if the child was breast-fed. Initially, Westrupp’s team discovered that children born by C-section were much more likely to have a medical condition at age two or three 3, use prescribed medicines at age 6 or 7, and to weigh even more at age 8 or 9. However, the child’s excess body weight reflected the mother’s weight problems, not being born by C-section, Westrupp said.